The simultaneous administration of medicaments containing calcium (eg, acetolyte) may lead to pathological increases of the serum calcium level or intensification.
As the uremic symptoms improve under Renoket, a possible administration of aluminum hydroxide should be reduced. Pay attention to a reduction of serum phosphate.
In order not to interfere with absorption, do not take drugs together with Renoket that form sparingly soluble compounds with calcium [eg, tetracyclines, quinolone (eg, ciprofloxacin and norfloxacin), iron-, fluoride- and estramustin-containing drugs]. Between the intake of Renoket and drugs from the mentioned categories, a period of at least 2 hrs should pass. The susceptibility towards heart/cardiac-active glycosides and hence, also the risk of arrhythmia increases with the rise of the blood calcium concentration.
Other Services
Country
Account